IL1B and autoimmune disease: Since our data demonstrated that BVDU could inhibit IL-6, IL-12, IL-23 and IL-1β production in DCs, and these pro-inflammation cytokines played a critical role in initiating the autoimmune disease, we hypothesized that this drug might have promising potential in treating autoimmune disease.